Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin‐10‐deficient mice

Background: We recently showed that Bifidobacterium animalis is more prevalent within the colons of interleukin (IL)‐10‐deficient (−/−) mice than in wildtype (WT) animals colonized with the same specific pathogen‐free (SPF) fecal contents. Here we tested the ability of this organism to cause T‐cell‐mediated intestinal inflammation by introducing it into germ‐free (GF) IL‐10−/− mice. Methods: GF IL‐10−/− or WT mice were monoassociated with Bifidobacterium animalis subsp. animalis ATCC (American Type Culture Collection, Manassas, VA) 25527T or with B. infantis ATCC 15697T. Inflammation was measured by blinded histologic scores of the duodenum, cecum, and colon and by spontaneous secretion of IL‐12/IL‐23 p40 from colonic explants. Bacterial antigen‐specific CD4+ mesenteric lymph node (MLN) T‐cell recall responses were measured in response to antigen‐presenting cells (APC) pulsed with bacterial lysates. Results: B. animalis caused marked duodenal inflammation and mild colitis in monoassociated IL‐10−/− mice, whereas the intestinal tracts of WT animals remained free of inflammation. B. infantis colonization resulted in mild inflammation in the duodena of IL‐10−/− mice. CD4+ MLN T cells from B. animalis monoassociated IL‐10−/− mice secreted high levels of IFN‐&ggr; and IL‐17 in response to B. animalis lysate. B. animalis equally colonized the different intestinal regions of WT and IL‐10−/− mice. Conclusions: B. animalis, a traditional probiotic species that is expanded in experimental colitis in this model, induces marked duodenal and mild colonic inflammation and TH1/TH17 immune responses when introduced alone into GF IL‐10−/− mice. This suggests a potential pathogenic role for this commensal bacterial species in a susceptible host.

[1]  R. Sartor,et al.  W1183 Differential In Vitro Epithelial Translocation and Resistance to Phagocyte Uptake and Killing By Escherichia coli Strains Correlate with Their Ability to Induce Colitis in Monoassociated IL-10−/− Mice , 2008 .

[2]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[3]  C. Jobin,et al.  Dual‐association of gnotobiotic Il‐10−/− mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis , 2007, Inflammatory bowel diseases.

[4]  T. Churchill,et al.  Epithelial barrier disruption allows nondisease‐causing bacteria to initiate and sustain IBD in the IL‐10 gene‐deficient mouse , 2007, Inflammatory bowel diseases.

[5]  F. Shanahan,et al.  Probiotic effects on inflammatory bowel disease. , 2007, The Journal of nutrition.

[6]  K. Michaelsen,et al.  Dose–response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults , 2006, European Journal of Clinical Nutrition.

[7]  M. Sanders Summary of Probiotic Activities of Bifidobacterium lactis HN019 , 2006, Journal of clinical gastroenterology.

[8]  R. Sartor Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[9]  F. Shanahan,et al.  Role of interleukin (IL‐10) in probiotic‐mediated immune modulation: an assessment in wild‐type and IL‐10 knock‐out mice , 2006, Clinical and experimental immunology.

[10]  J. Rumessen,et al.  Probiotic treatment of collagenous colitis: A randomized, double‐blind, placebo‐controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis , 2006, Inflammatory bowel diseases.

[11]  C. Matuchansky,et al.  Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits , 2005, Alimentary pharmacology & therapeutics.

[12]  R. Bibiloni,et al.  Analysis of the large bowel microbiota of colitic mice using PCR/DGGE , 2005, Letters in applied microbiology.

[13]  R. Fedorak,et al.  Association with Selected Bacteria Does Not Cause Enterocolitis in IL-10 Gene-Deficient Mice Despite a Systemic Immune Response , 2005, Digestive Diseases and Sciences.

[14]  R. Sartor,et al.  Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. , 2005, Gastroenterology.

[15]  J. Walter,et al.  A High-Molecular-Mass Surface Protein (Lsp) and Methionine Sulfoxide Reductase B (MsrB) Contribute to the Ecological Performance of Lactobacillus reuteri in the Murine Gut , 2005, Applied and Environmental Microbiology.

[16]  C. Jobin,et al.  STAT3 regulates NF-κB recruitment to the IL-12p40 promoter in dendritic cells , 2005 .

[17]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[18]  A. Palva,et al.  Genetic heterogeneity and functional properties of intestinal bifidobacteria , 2004, Journal of applied microbiology.

[19]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[20]  M. Ventura,et al.  Polyphasic taxonomic analysis of Bifidobacterium animalis and Bifidobacterium lactis reveals relatedness at the subspecies level: reclassification of Bifidobacterium animalis as Bifidobacterium animalis subsp. animalis subsp. nov. and Bifidobacterium lactis as Bifidobacterium animalis subsp. lactis , 2004, International journal of systematic and evolutionary microbiology.

[21]  R Balfour Sartor,et al.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.

[22]  L. De Vuyst,et al.  Short Fractions of Oligofructose Are Preferentially Metabolized by Bifidobacterium animalis DN-173 010 , 2004, Applied and Environmental Microbiology.

[23]  C. Moskaluk,et al.  Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis. , 2003, Gastroenterology.

[24]  W. Hammes,et al.  Safety of probiotics that contain lactobacilli or bifidobacteria. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  T. Warner,et al.  Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. , 2002, The American journal of pathology.

[26]  P. Marteau,et al.  Bifidobacterium animalis strain DN‐173 010 shortens the colonic transit time in healthy women: a double‐blind, randomized, controlled study , 2002, Alimentary pharmacology & therapeutics.

[27]  R. Sartor,et al.  Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice. , 2001, Gastroenterology.

[28]  S. Yamazaki,et al.  Probiotics and safety. , 2001, The American journal of clinical nutrition.

[29]  R. Sartor,et al.  Helicobacter hepaticus Does Not Induce or Potentiate Colitis in Interleukin-10-Deficient Mice , 2000, Infection and Immunity.

[30]  F. Gavini,et al.  A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces , 2000, Journal of applied microbiology.

[31]  K. Wilson,et al.  Differential Induction of Colitis and Gastritis in HLA-B27 Transgenic Rats Selectively Colonized with Bacteroides vulgatus or Escherichia coli , 1999, Infection and Immunity.

[32]  V. Godfrey,et al.  IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[33]  R. Sartor,et al.  Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.

[34]  T. Mitsuoka,et al.  Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. , 1998, International journal of food microbiology.

[35]  R. Hammer,et al.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. , 1996, The Journal of clinical investigation.

[36]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[37]  J. Lemeland,et al.  Bifidobacterium from fermented milks: survival during gastric transit. , 1991, Journal of dairy science.

[38]  S. Feighner,et al.  Lactobacilli and bile salt hydrolase in the murine intestinal tract , 1989, Applied and environmental microbiology.

[39]  P. Gopal,et al.  Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. , 2007, The journal of nutrition, health & aging.

[40]  R. Sartor,et al.  STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. , 2005, Blood.

[41]  J. Mcghee,et al.  CD4 CD45RB Hi Interleukin-4 Defective T Cells Elicit Antral Gastritis and Duodenitis , 2004 .

[42]  Manfred Dietel,et al.  Mucosal flora in inflammatory bowel disease. , 2002, Gastroenterology.